Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Coluracetam | Oxiracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 20-80 mg/day divided into 2-3 doses | 800-2400 mg/day divided into 2-3 doses |
| Timing | Morning and early afternoon. Sublingual administration may provide faster onset. With or without food. | Morning and early afternoon; avoid evening dosing due to mild stimulatory effect. Can be taken with or without food (water-soluble). |
| Cycle Duration | Cycles of 4-8 weeks on, 2-4 weeks off | Cycles of 8-12 weeks on, 4 weeks off |
| Evidence Level | animal_plus_anecdotal | moderate_human |
Enhances high-affinity choline uptake (HACU) via a unique mechanism distinct from other racetams — it increases HACU even in damaged cholinergic neurons, suggesting a choline uptake enhancement rather than mere stimulation. This HACU enhancement persists even after the compound has been cleared, indicating a lasting modification of choline transporter activity. Also shows affinity for AMPA receptors.
20-80 mg/day divided into 2-3 doses
Morning and early afternoon. Sublingual administration may provide faster onset. With or without food.
Cycles of 4-8 weeks on, 2-4 weeks off
Modulates cholinergic neurotransmission by preventing scopolamine-induced decreases of acetylcholine in the hippocampus and cortex. Enhances D-aspartate release and modulates AMPA receptor activity. Demonstrates mild stimulatory properties without affecting dopaminergic or serotonergic systems, making it a 'cleaner' cognitive enhancer among racetams.
800-2400 mg/day divided into 2-3 doses
Morning and early afternoon; avoid evening dosing due to mild stimulatory effect. Can be taken with or without food (water-soluble).
Cycles of 8-12 weeks on, 4 weeks off
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →